Provided by Tiger Fintech (Singapore) Pte. Ltd.

HilleVax, Inc.

2.06
-0.0500-2.37%
Post-market: 2.060.00000.00%13:00 EDT
Volume:59.47K
Turnover:122.75K
Market Cap:102.19M
PE:-0.96
High:2.10
Open:2.10
Low:2.05
Close:2.11
Loading ...
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Correspondence

Form CORRESP - Correspondence
Mar 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 18, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2023

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities